Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
21.04B | 16.44B | 10.58B | 7.14B | 3.78B | Gross Profit |
3.56B | 2.21B | 1.55B | 1.17B | 1.01B | EBIT |
980.39M | 547.37M | 313.70M | 183.89M | 264.00M | EBITDA |
1.04B | 609.73M | 372.49M | 219.95M | 266.00M | Net Income Common Stockholders |
647.57M | 336.17M | 172.42M | 50.23M | 152.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
9.54B | 6.20B | 1.46B | 2.04B | 1.38B | Total Assets |
35.75B | 21.49B | 10.93B | 9.05B | 6.27B | Total Debt |
5.94B | 3.03B | 1.18B | 2.27B | 1.36B | Net Debt |
-1.92B | -3.17B | -282.28M | 229.97M | -22.00M | Total Liabilities |
31.94B | 18.38B | 9.88B | 8.17B | 13.37M | Stockholders Equity |
3.81B | 3.11B | 1.04B | 871.30M | 317.00M |
Cash Flow | Free Cash Flow | |||
-1.26B | 1.27B | 196.17M | -745.75M | 317.86M | Operating Cash Flow |
-1.21B | 1.29B | 274.83M | -513.92M | 680.78M | Investing Cash Flow |
-134.78M | -122.80M | 237.44M | -239.15M | -636.57M | Financing Cash Flow |
2.91B | 3.57B | -1.09B | 1.41B | 1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $746.08B | 8.77 | 17.77% | 2.56% | 8.47% | -19.41% | |
77 Outperform | ¥20.51B | 11.24 | 4.74% | 2.85% | 0.57% | ||
69 Neutral | $539.88B | 8.19 | 12.46% | 3.46% | 23.35% | 46.19% | |
69 Neutral | $625.81B | 43.88 | 2.92% | 1.81% | 6.28% | -30.10% | |
66 Neutral | $94.00B | 9.38 | 10.73% | 3.23% | 12.06% | -8.90% | |
64 Neutral | $12.52B | 9.82 | 7.95% | 16985.69% | 12.70% | -4.60% | |
57 Neutral | ¥30.11B | 29.30 | 0.60% | 82.81% | 122.12% |